Biren Amin
Stock Analyst at Piper Sandler
(3.78)
# 1,996
Out of 5,032 analysts
649
Total ratings
41.5%
Success rate
4.1%
Average return
Main Sectors:
Stocks Rated by Biren Amin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| REGN Regeneron Pharmaceuticals | Reiterated: Buy | $854 | $738.72 | +15.61% | 47 | Oct 2, 2026 | |
| SLDB Solid Biosciences | Reiterated: Buy | $18 | $6.92 | +160.12% | 17 | Sep 30, 2026 | |
| OCUL Ocular Therapeutix | Reiterated: Buy | $31 | $7.34 | +322.34% | 28 | Sep 29, 2026 | |
| MNPR Monopar Therapeutics | Reiterated: Buy | $101 → $123 | $79.57 | +54.58% | 10 | Sep 28, 2026 | |
| KYMR Kymera Therapeutics | Reiterated: Buy | $140 | $105.98 | +32.10% | 4 | Sep 23, 2026 | |
| BBOT BridgeBio Oncology Therapeutics | Reiterated: Buy | $21 | $3.50 | +500.00% | 10 | Sep 9, 2026 | |
| ACRS Aclaris Therapeutics | Reiterated: Buy | $11 | $3.70 | +197.30% | 7 | Aug 31, 2026 | |
| BBIO BridgeBio Pharma | Reiterated: Buy | $115 | $66.96 | +71.74% | 35 | Aug 31, 2026 | |
| OKYO OKYO Pharma | Reiterated: Buy | $7 | $1.46 | +379.45% | 3 | Aug 27, 2026 | |
| ALLO Allogene Therapeutics | Reiterated: Buy | $10 | $1.46 | +584.93% | 23 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.9054 | +673.14% | 2 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $19.31 | +70.90% | 16 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $2 | $0.5601 | +257.08% | 1 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 → $7 | $3.79 | +84.70% | 10 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $4.39 | +173.35% | 11 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 → $14 | $2.36 | +493.22% | 9 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $6 | $0.9981 | +501.14% | 8 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $4.38 | +151.14% | 4 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $17.31 | +15.54% | 28 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $71 | $28.38 | +150.18% | 14 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $13.57 | +157.92% | 24 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.3218 | +2,075.26% | 8 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $16.09 | +198.32% | 8 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $22.60 | +54.87% | 10 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $7 | $2.66 | +163.16% | 3 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $51 | $5.78 | +782.35% | 4 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $10 → $0.7 | $0.365 | n/a | 5 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $63 → $70 | $2.67 | n/a | 4 | May 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $142 → $94 | $145.51 | n/a | 44 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 | $18.72 | n/a | 4 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $0.3317 | n/a | 20 | Jul 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $19 | $7.50 | n/a | 2 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $8 → $7 | $7.49 | n/a | 11 | Mar 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $51 | $2.88 | n/a | 2 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $59 → $34 | $26.81 | n/a | 2 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $1.42 | n/a | 5 | Feb 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $32 | $3.78 | n/a | 2 | Jan 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $39 → $109 | $2.29 | n/a | 3 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $43 → $60 | $12.96 | n/a | 18 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.79 | n/a | 3 | Dec 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $15 → $10 | $0.364 | n/a | 2 | Sep 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $9 | $2.56 | n/a | 12 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $36 → $18 | $41.65 | n/a | 32 | Jul 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $41 | $66.70 | n/a | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $18 → $2 | $3.43 | n/a | 4 | May 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $0.0001 | n/a | 1 | Mar 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $11 | $3.31 | n/a | 3 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 | $47.89 | n/a | 10 | Nov 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $3.5 | $9.69 | n/a | 4 | Nov 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $10 → $1 | $0.012 | n/a | 19 | Oct 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 → $7.5 | $31.01 | n/a | 19 | Aug 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $26 | $0.0001 | n/a | 3 | Jun 18, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $10.56 | n/a | 1 | Jun 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $128.00 | n/a | 1 | Mar 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $155 | $502.31 | n/a | 1 | Jul 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $5.00 | n/a | 1 | Jun 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $1.40 | n/a | 7 | Jun 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $0.572 | n/a | 9 | May 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 → $15 | $25.45 | n/a | 10 | Mar 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6 → $8.75 | $13.00 | n/a | 7 | Jan 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 | $7.75 | n/a | 7 | Jan 12, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.0001 | n/a | 1 | Mar 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $11 | $36.57 | n/a | 7 | Mar 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $1.07 | n/a | 1 | Feb 22, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6 → $7 | $1.11 | n/a | 6 | Oct 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 | $0.1831 | n/a | 1 | Aug 22, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $39.91 | n/a | 7 | May 15, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $6 → $4 | $58.33 | n/a | 2 | May 2, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $144.23 | n/a | 1 | Jan 27, 2010 |
Regeneron Pharmaceuticals
Oct 2, 2026
Reiterated: Buy
Price Target: $854
Current: $738.72
Upside: +15.61%
Solid Biosciences
Sep 30, 2026
Reiterated: Buy
Price Target: $18
Current: $6.92
Upside: +160.12%
Ocular Therapeutix
Sep 29, 2026
Reiterated: Buy
Price Target: $31
Current: $7.34
Upside: +322.34%
Monopar Therapeutics
Sep 28, 2026
Reiterated: Buy
Price Target: $101 → $123
Current: $79.57
Upside: +54.58%
Kymera Therapeutics
Sep 23, 2026
Reiterated: Buy
Price Target: $140
Current: $105.98
Upside: +32.10%
BridgeBio Oncology Therapeutics
Sep 9, 2026
Reiterated: Buy
Price Target: $21
Current: $3.50
Upside: +500.00%
Aclaris Therapeutics
Aug 31, 2026
Reiterated: Buy
Price Target: $11
Current: $3.70
Upside: +197.30%
BridgeBio Pharma
Aug 31, 2026
Reiterated: Buy
Price Target: $115
Current: $66.96
Upside: +71.74%
OKYO Pharma
Aug 27, 2026
Reiterated: Buy
Price Target: $7
Current: $1.46
Upside: +379.45%
Allogene Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: $10
Current: $1.46
Upside: +584.93%
Aug 13, 2026
Reiterated: Buy
Price Target: $7
Current: $0.9054
Upside: +673.14%
Aug 12, 2026
Reiterated: Buy
Price Target: $33
Current: $19.31
Upside: +70.90%
Aug 12, 2026
Initiated Coverage: Buy
Price Target: $2
Current: $0.5601
Upside: +257.08%
Aug 12, 2026
Reiterated: Hold
Price Target: $12 → $7
Current: $3.79
Upside: +84.70%
Aug 12, 2026
Reiterated: Buy
Price Target: $12
Current: $4.39
Upside: +173.35%
Aug 11, 2026
Rated: Buy
Price Target: $16 → $14
Current: $2.36
Upside: +493.22%
Aug 7, 2026
Reiterated: Buy
Price Target: $4 → $6
Current: $0.9981
Upside: +501.14%
Aug 7, 2026
Reiterated: Buy
Price Target: $11
Current: $4.38
Upside: +151.14%
Aug 6, 2026
Reiterated: Hold
Price Target: $20
Current: $17.31
Upside: +15.54%
Jul 30, 2026
Reiterated: Buy
Price Target: $71
Current: $28.38
Upside: +150.18%
Jun 23, 2026
Reiterated: Buy
Price Target: $35
Current: $13.57
Upside: +157.92%
Jun 2, 2026
Reiterated: Buy
Price Target: $7
Current: $0.3218
Upside: +2,075.26%
Jun 1, 2026
Reiterated: Buy
Price Target: $48
Current: $16.09
Upside: +198.32%
May 13, 2026
Reiterated: Buy
Price Target: $35
Current: $22.60
Upside: +54.87%
Mar 30, 2026
Reiterated: Hold
Price Target: $5 → $7
Current: $2.66
Upside: +163.16%
Oct 20, 2025
Reiterated: Buy
Price Target: $35 → $51
Current: $5.78
Upside: +782.35%
Mar 21, 2025
Downgraded: Hold
Price Target: $10 → $0.7
Current: $0.365
Upside: n/a
May 19, 2023
Reiterated: Buy
Price Target: $63 → $70
Current: $2.67
Upside: n/a
Mar 3, 2022
Downgraded: Hold
Price Target: $142 → $94
Current: $145.51
Upside: n/a
Aug 24, 2021
Reiterated: Buy
Price Target: $56
Current: $18.72
Upside: n/a
Jul 23, 2021
Reiterated: Buy
Price Target: $25
Current: $0.3317
Upside: n/a
Mar 17, 2021
Reiterated: Buy
Price Target: $14 → $19
Current: $7.50
Upside: n/a
Mar 15, 2021
Rated: Buy
Price Target: $8 → $7
Current: $7.49
Upside: n/a
Mar 12, 2021
Reiterated: Buy
Price Target: $34 → $51
Current: $2.88
Upside: n/a
Feb 16, 2021
Downgraded: Hold
Price Target: $59 → $34
Current: $26.81
Upside: n/a
Feb 10, 2021
Reiterated: Buy
Price Target: $21
Current: $1.42
Upside: n/a
Jan 15, 2021
Reiterated: Buy
Price Target: $27 → $32
Current: $3.78
Upside: n/a
Dec 21, 2020
Reiterated: Buy
Price Target: $39 → $109
Current: $2.29
Upside: n/a
Dec 21, 2020
Reiterated: Buy
Price Target: $43 → $60
Current: $12.96
Upside: n/a
Dec 9, 2020
Downgraded: Hold
Price Target: n/a
Current: $1.79
Upside: n/a
Sep 14, 2020
Downgraded: Hold
Price Target: $15 → $10
Current: $0.364
Upside: n/a
Aug 7, 2020
Reiterated: Hold
Price Target: $10 → $9
Current: $2.56
Upside: n/a
Jul 29, 2020
Reiterated: Hold
Price Target: $36 → $18
Current: $41.65
Upside: n/a
Jul 7, 2020
Initiated Coverage: Buy
Price Target: $41
Current: $66.70
Upside: n/a
May 29, 2020
Downgraded: Hold
Price Target: $18 → $2
Current: $3.43
Upside: n/a
Mar 27, 2020
Initiated Coverage: Buy
Price Target: $6
Current: $0.0001
Upside: n/a
Dec 3, 2019
Reiterated: Buy
Price Target: $6 → $11
Current: $3.31
Upside: n/a
Nov 8, 2019
Downgraded: Hold
Price Target: $12
Current: $47.89
Upside: n/a
Nov 12, 2018
Reiterated: Hold
Price Target: $4 → $3.5
Current: $9.69
Upside: n/a
Oct 10, 2018
Downgraded: Hold
Price Target: $10 → $1
Current: $0.012
Upside: n/a
Aug 10, 2018
Reiterated: Hold
Price Target: $15 → $7.5
Current: $31.01
Upside: n/a
Jun 18, 2018
Reiterated: Buy
Price Target: $21 → $26
Current: $0.0001
Upside: n/a
Jun 5, 2018
Initiated Coverage: Buy
Price Target: $17
Current: $10.56
Upside: n/a
Mar 19, 2018
Initiated Coverage: Buy
Price Target: $12
Current: $128.00
Upside: n/a
Jul 11, 2017
Initiated Coverage: Buy
Price Target: $155
Current: $502.31
Upside: n/a
Jun 22, 2017
Reiterated: Buy
Price Target: $17
Current: $5.00
Upside: n/a
Jun 6, 2017
Reiterated: Buy
Price Target: $47
Current: $1.40
Upside: n/a
May 15, 2017
Reiterated: Hold
Price Target: $3
Current: $0.572
Upside: n/a
Mar 10, 2017
Reiterated: Hold
Price Target: $9 → $15
Current: $25.45
Upside: n/a
Jan 18, 2017
Downgraded: Hold
Price Target: $6 → $8.75
Current: $13.00
Upside: n/a
Jan 12, 2017
Reiterated: Hold
Price Target: $1.5
Current: $7.75
Upside: n/a
Mar 9, 2016
Reiterated: Buy
Price Target: $9
Current: $0.0001
Upside: n/a
Mar 9, 2016
Reiterated: Buy
Price Target: $12 → $11
Current: $36.57
Upside: n/a
Feb 22, 2016
Reiterated: Buy
Price Target: $15
Current: $1.07
Upside: n/a
Oct 30, 2015
Rated: Buy
Price Target: $6 → $7
Current: $1.11
Upside: n/a
Aug 22, 2014
Downgraded: Hold
Price Target: $5
Current: $0.1831
Upside: n/a
May 15, 2014
Initiated Coverage: Buy
Price Target: $15
Current: $39.91
Upside: n/a
May 2, 2014
Rated: Hold
Price Target: $6 → $4
Current: $58.33
Upside: n/a
Jan 27, 2010
Reiterated: Buy
Price Target: $29
Current: $144.23
Upside: n/a